We conducted a multicenter phase III trial of tamoxifen 5 mg d versus placebo administered for 3 years in women 75 years of age or younger with an Eastern Cooperative Oncology Group performance status of 1 or less and operated hormone sensitive ER or progesterone receptor 1 or unknown breast intraepithelial neoplasia ADH, DCIS, or LCIS <a href=https://fastpriligy.top/>priligy buy online usa</a>